Evercore ISI Group Maintains Outperform on Medtronic, Lowers Price Target to $106

Benzinga Newsdesk www.benzinga.com Negative 94.5%

Neg 94.5% Neu 0% Pos 0%

Evercore ISI Group analyst Vijay Kumar maintains Medtronic (NYSE:MDT) with a Outperform and lowers the price target from $108 to $106.